New radiation combo may boost second stem cell transplants for blood cancer relapses
NCT ID NCT02333162
First seen Mar 15, 2026 · Last updated May 23, 2026 · Updated 14 times
Summary
This study tests adding a precise, low-toxicity radiation to the bone marrow (IMTMI) along with standard chemotherapy before a second donor stem cell transplant. It includes up to 30 adults with blood cancers like leukemia that have returned after a first transplant. The goal is to find the safest radiation dose and see if this approach helps control the cancer and reduces side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT ADULT ACUTE MYELOID LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Chicago Comprehensive Cancer Center
Chicago, Illinois, 60637, United States
Conditions
Explore the condition pages connected to this study.